These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14694957)

  • 21. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of endotracheal instillation of iloprost for persistent pulmonary hypertension of the newborn.
    Okbay Gunes A; Ciftel M; Timur ME; Dedebali C; Pirdal BZ
    Cardiol Young; 2022 Dec; 32(12):1894-1900. PubMed ID: 34986915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in the use of inhaled nitric oxide therapy in the newborn.
    Kinsella JP; Abman SH
    Clin Perinatol; 1998 Mar; 25(1):203-17. PubMed ID: 9523083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.
    Kinsella JP; Neish SR; Shaffer E; Abman SH
    Lancet; 1992 Oct; 340(8823):819-20. PubMed ID: 1357246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent pulmonary hypertension of the term neonate: a strategy for management.
    Mok Q; Yates R; Tasker RC
    Eur J Pediatr; 1999 Oct; 158(10):825-7. PubMed ID: 10486085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute responses to inhalation of Iloprost in patients with pulmonary hypertension.
    Zhang HL; Liu ZH; Wang Y; Xiong CM; Ni XH; He JG; Luo Q; Zhao ZH; Zhao Q; Sun XG
    Chin Med J (Engl); 2012 Aug; 125(16):2826-31. PubMed ID: 22932074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
    Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
    Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effect of aerosolized iloprost and oxygen on assessment of pulmonary vasoreactivity in children with pulmonary hypertension.
    Elkiran O; Karakurt C; Koçak G
    Anadolu Kardiyol Derg; 2014 Jun; 14(4):383-8. PubMed ID: 24818629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide in the management of persistent pulmonary hypertension of the newborn--an unusual cause of failure.
    Jerwood DC; Stokes MA
    Paediatr Anaesth; 1995; 5(3):193-5. PubMed ID: 7489441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled iloprost in pulmonary arterial hypertension.
    Baker SE; Hockman RH
    Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn.
    Kinsella JP; Abman SH
    Eur J Pediatr; 1998 Jan; 157 Suppl 1():S28-30. PubMed ID: 9462904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide prevents severe hypoxemia in newborns with acute lung disease and pulmonary hypertension.
    Day RW
    Pediatrics; 1998 Jun; 101(6):1093-4. PubMed ID: 9614429
    [No Abstract]   [Full Text] [Related]  

  • 34. Current and future therapeutic options for persistent pulmonary hypertension in the newborn.
    Rao S; Bartle D; Patole S
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy.
    Kinsella JP; Abman SH
    J Perinatol; 1996; 16(2 Pt 2 Su):S24-7. PubMed ID: 8732545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review.
    Mulligan C; Beghetti M
    Pediatr Crit Care Med; 2012 Jul; 13(4):472-80. PubMed ID: 21926655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
    Schenk P; Petkov V; Madl C; Kramer L; Kneussl M; Ziesche R; Lang I
    Chest; 2001 Jan; 119(1):296-300. PubMed ID: 11157622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
    Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous inhaled iloprost in a neonate with d-transposition of the great arteries and severe pulmonary arterial hypertension.
    Dykes JC; Torres M; Alexander PJ
    Cardiol Young; 2016 Mar; 26(3):571-3. PubMed ID: 26220108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.
    Kahveci H; Yilmaz O; Avsar UZ; Ciftel M; Kilic O; Laloglu F; Ozturk K
    Pediatr Pulmonol; 2014 Dec; 49(12):1205-13. PubMed ID: 24420987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.